AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 191 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,937 | -43.4% | 17,109 | -29.5% | 0.01% | -44.4% |
| Q2 2023 | $235,001 | -35.7% | 24,277 | -27.2% | 0.01% | -40.0% |
| Q1 2023 | $365,560 | -72.8% | 33,354 | -75.1% | 0.02% | -74.1% |
| Q2 2022 | $1,345,000 | -11.3% | 133,853 | +9.3% | 0.06% | -10.8% |
| Q1 2022 | $1,517,000 | +162.0% | 122,500 | +174.0% | 0.06% | +16.1% |
| Q2 2021 | $579,000 | +14.0% | 44,700 | +29.6% | 0.06% | -45.1% |
| Q3 2020 | $508,000 | – | 34,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
| NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
| Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
| Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
| HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
| Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
| Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |